Holding for the long haul is a good plan. Buying and selling the peaks and valleys is a good plan also. Thermodox is a like a pipeline within a single drug as it's uses to fight cancer should prove to be effective across the entire body. No, it is not a shoe in. Any first time drug runs a higher risk of rejection...
If Celsion is smart, they might be able to include the clinical studies of other trials for other targeted cancer areas in the FDA label if they get approved for liver cancer.
Market Data 
Markets 
AI
